Oncolytics Biotech
ONCY
#9215
Rank
โ‚ฌ88.68 M
Marketcap
0,82ย โ‚ฌ
Share price
-7.79%
Change (1 day)
13.70%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -โ‚ฌ22.18 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.46 Million a decrease over its 2023 earnings that were of -โ‚ฌ21.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ22.18 Million3.35%
2024 -โ‚ฌ21.46 Million1.01%
2023 -โ‚ฌ21.24 Million23.39%
2022 -โ‚ฌ17.22 Million-1.98%
2021 -โ‚ฌ17.56 Million9.1%
2020 -โ‚ฌ16.1 Million22.64%
2019 -โ‚ฌ13.13 Million22.78%
2018 -โ‚ฌ10.69 Million4.1%
2017 -โ‚ฌ10.27 Million4.87%
2016 -โ‚ฌ9.8 Million8.75%
2015 -โ‚ฌ9.01 Million-37.06%
2014 -โ‚ฌ14.31 Million-26.2%
2013 -โ‚ฌ19.39 Million-37.39%
2012 -โ‚ฌ30.96 Million28.8%
2011 -โ‚ฌ24.04 Million46.02%
2010 -โ‚ฌ16.46 Million35.64%
2009 -โ‚ฌ12.14 Million-14.2%
2008 -โ‚ฌ14.15 Million-0.52%
2007 -โ‚ฌ14.22 Million24.6%
2006 -โ‚ฌ11.42 Million45.34%
2005 -โ‚ฌ7.86 Million-11.8%
2004 -โ‚ฌ8.91 Million115.36%
2003 -โ‚ฌ4.14 Million13.86%
2002 -โ‚ฌ3.63 Million-5.45%
2001 -โ‚ฌ3.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ18.97 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.77 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-โ‚ฌ0.65 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚ฌ4.63 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.81 B-8,750.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-โ‚ฌ24.49 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA